Ixaka is a private UK-based cell and gene therapy company with operations in the UK, Spain and France.  The company is focused on the natural power of the body to cure disease.

Our proprietary technologies enhance the inherent therapeutic power of cells by targeting curative cells to the site of disease and by directly modifying cells within the body to improve their therapeutic action.

Ixaka’s technologies – concentrated multi-cell therapies and targeted nano-particles – demonstrate potential for the treatment of a broad range of serious diseases across oncology, cardiovascular, neurological and ocular diseases, and genetic disorders.

Biotechnology

Ixaka

Joe Dupere

George O'Rourke

Nick Robbins-Cherry

Gilbert Wagener

Christian Hoyer Millar

Roxana Tundrea

Géraldine SARAGOUSSI

Victoria García

Eva López

Karen Miller

Sadia L’Baouch

The leadership team at Ixaka has experience in a variety of industries, including finance, healthcare, and pharmaceuticals. They have also received education from some of the top universities in the world, including Cornell, McGill, and the University of Bath.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Ixaka

Board of Directors

CEO and Executive Team